文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

氨甲环酸给药与创伤患者死亡及血栓栓塞事件的关联:系统评价与Meta分析

Association of Tranexamic Acid Administration With Mortality and Thromboembolic Events in Patients With Traumatic Injury: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Netw Open · 2022-03-01
一句话结论31项研究43 473例创伤患者显示,氨甲环酸与1个月死亡率降低相关(RR 0.83,95%CI 0.71-0.97),但血栓栓塞风险担忧仍存。

该系统评价与Meta分析检索PubMed、Embase和Cochrane Library(1986年至2021年),纳入31项研究共43 473例15岁及以上创伤及创伤性脑损伤患者,比较氨甲环酸与未治疗或安慰剂。Meta分析显示氨甲环酸与1个月死亡率显著降低相关(RR 0.83,95%CI 0.71-0.97;I²=35%);24小时死亡率、总死亡率和血栓栓塞事件的Meta分析结果异质性大,无法合并。作者认为氨甲环酸可能对多种创伤人群有益,但对潜在血栓栓塞事件的合理担忧仍然存在。

要点

  • 31项研究43 473例创伤患者,氨甲环酸组1个月死亡率较对照组显著降低(RR 0.83,95%CI 0.71-0.97;I²=35%)。
  • 24小时死亡率、总死亡率和血栓栓塞事件的Meta分析结果异质性大,无法合并。
  • 进一步临床异质性分析显示,创伤人群和试验条件差异显著。
  • 作者认为氨甲环酸可能对多种创伤人群有益,但对潜在血栓栓塞事件的合理担忧仍然存在。

适用人群与场景

  • 15岁及以上创伤及创伤性脑损伤患者,研究比较氨甲环酸与未治疗或安慰剂。
  • 纳入随机临床试验和观察性研究,发表于1986年至2021年,语言限英文或德文。

研究设计与关键结果

  • 系统评价与Meta分析,纳入31项研究共43 473例患者,检索PubMed、Embase和Cochrane Library(1986年至2021年)。
  • 氨甲环酸组1个月死亡率较对照组显著降低(RR 0.83,95%CI 0.71-0.97;I²=35%)。
  • 24小时死亡率、总死亡率和血栓栓塞事件的Meta分析结果异质性大,无法合并。
  • 进一步临床异质性分析显示,创伤人群和试验条件差异显著。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,遵循Cochrane Handbook和PRISMA指南,由2名独立评价者提取数据,采用逆方差随机效应模型合并。
  • 局限:24小时死亡率、总死亡率和血栓栓塞事件的Meta分析结果异质性大,无法合并;进一步临床异质性分析显示创伤人群和试验条件差异显著。
  • 局限:原文未报告其他局限性。

对床旁实践的改变

  • 作者认为氨甲环酸可能对多种创伤人群有益,但对潜在血栓栓塞事件的合理担忧仍然存在。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Tranexamic acid is widely available and used off-label in patients with bleeding traumatic injury, although the literature does not consistently agree on its efficacy and safety.

OBJECTIVE: To examine the association of tranexamic acid administration with mortality and thromboembolic events compared with no treatment or with placebo in patients with traumatic injury in the literature.

DATA SOURCES: On March 23, 2021, PubMed, Embase, and the Cochrane Library were searched for eligible studies published between 1986 and 2021.

STUDY SELECTION: Randomized clinical trials and observational studies investigating tranexamic acid administration compared with no treatment or placebo among patients with traumatic injury and traumatic brain injury who were 15 years or older were included. Included studies were published in English or German. The electronic search yielded 1546 records, of which 71 were considered for full-text screening. The selection process was performed independently by 2 reviewers.

DATA EXTRACTION AND SYNTHESIS: The study followed the Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Data were extracted by 2 independent reviewers and pooled using the inverse-variance random-effects model.

MAIN OUTCOMES AND MEASURES: Outcomes were formulated before data collection and included mortality at 24 hours and 28 and 30 days (1 month) as well as the incidence of thromboembolic events and the amount of blood products administered. Owing to missing data, overall mortality was added and the amount of blood products administered was discarded.

RESULTS: Thirty-one studies with a total of 43 473 patients were included in the systematic review. The meta-analysis demonstrated that administration of tranexamic acid was associated with a significant decrease in 1-month mortality compared with the control cohort (risk ratio, 0.83 [95% CI, 0.71-0.97]; I2 = 35%). The results of meta-analyses for 24-hour and overall mortality and thromboembolic events were heterogeneous and could not be pooled. Further investigations on clinical heterogeneity showed that populations with trauma and trial conditions differed markedly.

CONCLUSIONS AND RELEVANCE: These findings suggest that tranexamic acid may be beneficial in various patient populations with trauma. However, reasonable concerns about potential thromboembolic events with tranexamic acid remain.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Karl V, Thorn S, Mathes T, et al. Association of Tranexamic Acid Administration With Mortality and Thromboembolic Events in Patients With Traumatic Injury: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022. PMID: 35230436. doi:10.1001/jamanetworkopen.2022.0625

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。